Webinar: New Non-dilutive Funding Resource for BioUtah Members
June 25, 2021
If you weren’t able to join the Government to Growth (G2G) webinar held on June 21, the recording is now available.
The webinar launched BioUtah’s new initiative to bring the vast array of the federal government’s non-dilutive funding opportunities to the doorstep of Utah’s life sciences community. BioUtah has contracted with G2G, Washington DC’s premier consulting firm for non-dilutive funding, to receive a detailed monthly report on the funding landscape. G2G will also be holding monthly webinars to assist BioUtah members in understanding the various funding options that fit our industry and how to navigate the system.
The monthly report is now available to all BioUtah members. To obtain the most recent report, simply request an access code. Follow-up webinars to review current non-dilutive funding opportunities will be held July 19 and August 16, 2021 at 1:00 PM MDT.
The recent webinar reviewed the June funding report.
Recent News
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
- Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
